Ligand Pharmaceuticals Statistics
Total Valuation
ALGS has a market cap or net worth of $47.98 million. The enterprise value is -$66.06 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALGS has 6.15 million shares outstanding. The number of shares has increased by 62.20% in one year.
| Current Share Class | 5.35M |
| Shares Outstanding | 6.15M |
| Shares Change (YoY) | +62.20% |
| Shares Change (QoQ) | +18.85% |
| Owned by Insiders (%) | 2.89% |
| Owned by Institutions (%) | 33.71% |
| Float | 2.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.06 |
| Forward PS | n/a |
| PB Ratio | 0.49 |
| P/TBV Ratio | 0.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.07.
| Current Ratio | 6.31 |
| Quick Ratio | 6.07 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -87.74% and return on invested capital (ROIC) is -52.81%.
| Return on Equity (ROE) | -87.74% |
| Return on Assets (ROA) | -40.30% |
| Return on Invested Capital (ROIC) | -52.81% |
| Return on Capital Employed (ROCE) | -68.60% |
| Revenue Per Employee | $45,343 |
| Profits Per Employee | -$1.06M |
| Employee Count | 70 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALGS has paid $346,000 in taxes.
| Income Tax | 346,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.92% in the last 52 weeks. The beta is 2.78, so ALGS's price volatility has been higher than the market average.
| Beta (5Y) | 2.78 |
| 52-Week Price Change | -41.92% |
| 50-Day Moving Average | 7.77 |
| 200-Day Moving Average | 15.24 |
| Relative Strength Index (RSI) | 47.80 |
| Average Volume (20 Days) | 65,629 |
Short Selling Information
The latest short interest is 391,884, so 6.37% of the outstanding shares have been sold short.
| Short Interest | 391,884 |
| Short Previous Month | 533,025 |
| Short % of Shares Out | 6.37% |
| Short % of Float | 13.32% |
| Short Ratio (days to cover) | 4.13 |
Income Statement
In the last 12 months, ALGS had revenue of $3.17 million and -$74.18 million in losses. Loss per share was -$9.47.
| Revenue | 3.17M |
| Gross Profit | -58.11M |
| Operating Income | -78.50M |
| Pretax Income | -75.52M |
| Net Income | -74.18M |
| EBITDA | -77.56M |
| EBIT | -78.50M |
| Loss Per Share | -$9.47 |
Full Income StatementBalance Sheet
The company has $122.95 million in cash and $6.88 million in debt, giving a net cash position of $116.07 million or $18.87 per share.
| Cash & Cash Equivalents | 122.95M |
| Total Debt | 6.88M |
| Net Cash | 116.07M |
| Net Cash Per Share | $18.87 |
| Equity (Book Value) | 101.87M |
| Book Value Per Share | 16.56 |
| Working Capital | 107.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$74.92 million and capital expenditures -$206,000, giving a free cash flow of -$75.12 million.
| Operating Cash Flow | -74.92M |
| Capital Expenditures | -206,000 |
| Free Cash Flow | -75.12M |
| FCF Per Share | -$12.21 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -2,473.35% |
| Pretax Margin | -2,326.34% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALGS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.20% |
| Shareholder Yield | -62.20% |
| Earnings Yield | -148.34% |
| FCF Yield | -150.21% |
Analyst Forecast
The average price target for ALGS is $70.00, which is 797.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $70.00 |
| Price Target Difference | 797.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 136.18% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 19, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 19, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
ALGS has an Altman Z-Score of -6.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.02 |
| Piotroski F-Score | 1 |
